The authors of this study have identified the upstream protein responsibile for the anti-ageing effects in mice, that this protein has anti-senescent effects on human cells, that this protein drops with age in humans, that it drops more in humans with age-related disease and that this protein could have a protective effect in multiple chronic diseases in humans based on mendelian randomization.
This implies a stronger therapeutic potential than just a "nothingburger study".